The report uses 2018-19 data from more than 36,000 hospitals, nursing homes and other healthcare facilities to analyze rates of central line-associated bloodstream infections, catheter-associated urinary tract infections, ventilator-associated events, surgical site infections, methicillin-resistant Staphylococcus aureus bloodstream events and Clostridioides difficile events.
Four national report findings for acute care hospitals:
1. Overall, U.S. hospitals reported a 7 percent decrease in CLABSIs from 2018 to 2019, with the largest decrease — 13 percent — in neonatal intensive care units.
2. CAUTIs dropped by 8 percent, with the largest decrease — 12 percent — reported by intensive care units.
3. VAEs increased by 2 percent, with the highest increase observed in ICUs.
4. There was no significant change in SSIs.
For the full report, click here.
More articles on infection control:
Hospitalized COVID-19 patients more likely to acquire, die from sepsis than flu patients, data suggests
COVID-19 patients most infectious 2 days before, 5 days after symptoms emerge, analysis finds
Staff meal breaks in the COVID-19 era: How 4 systems are limiting infection risks
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
